

SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.


Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.

A federal appeals court will soon have the opportunity to review its 2010 ruling which created super PACs, following a federal district court decision yesterday in a case led by Members of Congress seeking to end super PAC spending in US elections.
Lieu v. Federal Election Commission, which was filed in federal district court in Washington, D.C. in November 2016 on behalf of a bipartisan coalition of Members of Congress and 2016 congressional candidates led by Representative Ted Lieu (D-CA-33), Senator Jeff Merkley (D-OR), and the late Representative Walter Jones (R-NC-3), seeks the reversal of the March 2010 federal appeals court ruling in SpeechNow.org v. FEC. In that decision, the U.S. Court of Appeals for the D.C. Circuit concluded that the federal law limiting contributions to political action committees to $5,000 per person per year did not apply to political committees that promised to make only "independent" expenditures, thus unleashing super PACs.
"Super PACs weren't created by Congress, or the U.S. Supreme Court--they were created by a lower court decision, based on faulty assumptions, that has never been reviewed or revisited," says Ron Fein, Legal Director of Free Speech For People. "It's been almost a decade since the D.C. Circuit unleashed super PACs on our democracy, and it's clear that the experiment has failed. We look forward to giving the courts the opportunity to overrule the SpeechNow decision so we can rebuild our democracy."
"When huge corporations and the super-wealthy can drown out the voices of ordinary Americans, we've lost President Lincoln's vision of a government of the people, by the people, and for the people," says Senator Jeff Merkley, "We need to put 'We the People' back in charge, and that starts by closing the gaping super PAC loophole that has allowed dark money to overwhelm our elections. We look forward to making our argument before the U.S. Court of Appeals for the D.C. Circuit that the time has come for it to revisit and reverse its ruling that created super PACs."
"Since the SpeechNow.org v. Federal Election Commission decision, the amount of money being spent on our elections has exploded, adding fuel to the public perception of election corruption," says Congressman Ted Lieu. "Americans across the political spectrum want to see their elected officials responsive to them instead of big money donors. The idea that one person or one corporation can essentially buy an election is a threat to our democracy. I am honored to be a lead plaintiff in this case and look forward to demonstrating to the D.C. Circuit Court of Appeals that big money donors are now using super PACs to evade federal campaign contribution limits and undermine the integrity of our elections."
"For nearly a decade, the SpeechNow ruling by the U.S. Court of Appeals for the D.C. Circuit has allowed big money donors to evade federal campaign contribution limits and corrupt even further our political process," says John Bonifaz, Co-Founder and President of Free Speech For People. "The real-world experience of this ruling and the threat that super PACs pose to our democracy must now be reviewed by the D.C. Circuit. We look forward to advancing this case to the appellate level."
As explained by scholars and experts in political corruption and constitutional law, the SpeechNow ruling was legally erroneous at the time under Supreme Court precedent (including Citizens United). Unfortunately, then-Attorney General Eric Holder decided not to appeal SpeechNow to the Supreme Court, on the (clearly mistaken in retrospect) theory that the SpeechNow decision would "affect only a small subset of federally regulated contributions." This prediction, like the court's speculation that contributions to super PACs could not lead to corruption or the appearance of corruption, has proven incorrect with time. To this day, the Supreme Court has not reviewed the question. As a result, super PACs have become one of the primary vehicles for wealthy donors to evade campaign contribution limits designed to prevent corruption and the appearance of corruption. Meanwhile, Chief Justice Roberts has given signals that suggest that he would be willing to sustain limits on contributions to super PACs even within the framework of Citizens United.
On Thursday, February 28, the district court held that it was bound to follow SpeechNow until it is overturned. Indeed, as the court noted, the Lieu plaintiffs made clear that the case is intended as a vehicle for appeal to higher courts: "Plaintiffs acknowledge that the D.C. Circuit's interpretation of Citizens United in SpeechNow binds this Court unless SpeechNow has been overruled by either the D.C. Circuit sitting en banc, or the Supreme Court." Consequently, the district court concluded that it was required to dismiss the complaint in light of SpeechNow.
This frames the case for appeal to a higher court that can overrule SpeechNow. The next stage is an appeal to the U.S. Court of Appeals for the D.C. Circuit.
Free Speech For People, a national non-profit public interest organization founded on the day of the U.S. Supreme Court's ruling in Citizens United v. FEC, serves as co-lead counsel for the plaintiffs, along with Brad C. Deutsch and the law firm of Garvey Schubert Barer; Stephen A. Weisbrod and the law firm of Weisbrod Matteis & Copley; and veteran government accountability attorney Anne Weissmann. Mr. Deutsch served as lead counsel to the 2016 presidential campaign of Senator Bernie Sanders, and previously served for eight years as Chief of Staff and Senior Legal Advisor to Commissioner Steven T. Walther at the Federal Election Commission.
The legal team also includes a bipartisan group of distinguished scholars and practitioners in the law of the First Amendment, corruption, and government ethics: Professor Laurence Tribe (Harvard Law School); Professor Albert Alschuler (Univ. of Chicago Law School, emeritus); and Professor Richard Painter (Univ. of Minnesota Law School, and former chief ethics counsel to President George W. Bush).
For more information about the case, visit:
https://freespeechforpeople.org/lieu-v-federal-election-commission/
Free Speech For People is a national non-partisan non-profit organization founded on the day of the U.S. Supreme Court's ruling in Citizens United v. FEC that works to defend our democracy and our Constitution.
"We cannot afford to sit by while our NHS is picked apart by a foreign regime," said one member of Parliament.
One member of British Parliament called on the Labour government to defend the country's revered National Health Service "with everything we have and firmly stand up to the bully in the White House" after a study published Wednesday showed the UK-US pharmaceutical trade deal brokered last year is projected to cause 229,000 excess deaths as funding is stripped away from the NHS.
“It is a complete insult to patients who are suffering and dying on hospital trolleys and waiting months for treatment," said Helen Morgan of the Liberal Democrats Party regarding the new analysis. "We cannot afford to sit by while our NHS is picked apart by a foreign regime."
The study, conducted by researchers at the University of York, the University of Liverpool, and Christchurch Hospital in New Zealand and published in the British Medical Journal, found that £44.7 billion ($59.5 billion) will have to be diverted from health services by 2036 in order to pay for new medications under the deal.
The agreement was reached last December, with recently resigned Prime Minister Keir Starmer's government agreeing to pay 25% more for new US medications over the next decade. The NHS will double the percentage of gross domestic product that it allocates for pharmaceuticals, from 0.3% to 0.6%, with the spending increasing from 10% to 12% of the universal healthcare system's budget.
In exchange, the Trump administration agreed not to impose tariffs of up to 100% that he had threatened for UK medicines being imported to the US.
Science Minister Patrick Vallance insisted in April that the deal would give NHS patients access to "life-changing new medicines that they previously would have been denied" while boosting the UK's "life sciences sector" by avoiding Trump's tariffs.
"Scandalously, this backroom deal was not subject to any scrutiny in Parliament before being rushed through—and the government refuses to say what impact it will have on the NHS."
But Sir Ciarán Devane, chief executive of the NHS Alliance, told The Guardian that the study raised "serious questions" about whether Britons will truly benefit from the agreement.
"If billions of pounds are diverted away from frontline care to meet higher medicines costs, the consequences for prevention, community services, and the treatment of long-term conditions could be profound," said Devane. "The government must urgently publish the full impact assessment and ensure there is appropriate scrutiny of the deal if it could have such far-reaching implications for population health.”
The projected avoidable death toll in the study far exceeds that which the UK saw during the coronavirus pandemic, when 137,000 excess deaths were recorded between March 2020-June 2022.
"If the indirect effect on adult social care is also included, the increase in excess deaths is even greater (291,000),” reads the study.
The greatest number of excess deaths is projected to occur in patients suffering from cardiovascular, respiratory, and gastrointestinal issues as well as cancer.
Patients with “neurological, endocrine, musculoskeletal, and mental health problems" will also face "broader effects on quality of life," the research states.
The government has assured the public that "frontline services" will be protected, notes the report, but "the NHS will need to fund this deal from allocations made six months before the deal was agreed. The evidence suggests that if additional public expenditure was available, it could be more effectively deployed within the NHS itself."
The research projected that the greatest number of deaths would occur in cardiovascular, respiratory, gastrointestinal and cancer patients.
It added that there will also be broader harm caused to quality of life for patients in those sectors as well as “neurological, endocrine, musculoskeletal, and mental health problems”.
Tim Bierley, a campaigner with the UK-based group Global Justice Now, said that the report "adds to the overwhelming evidence that the Trump medicines deal risks taking a wrecking ball to our health and our economy."
"Billions that could be spent on recruiting more NHS staff, cutting [general practitioner] waiting times, or improving our hospital care are set to be siphoned off by corporate giants in the pharma industry," said Bierley, whose group has joined the campaign Just Treatment in filing a legal challenge against the deal. "Scandalously, this backroom deal was not subject to any scrutiny in Parliament before being rushed through—and the government refuses to say what impact it will have on the NHS."
"The next prime minister," said Bierley, "must change direction, stand up for our NHS, and unpick the mess left by their predecessors.”
Those arrested in the recent surge include a 56-year-old Catholic nun from Nigeria.
Ordered by the Trump White House to aggressively increase arrest rates, federal immigration officials have reportedly detained more than 10,000 people in just the last five days, intensifying fear in communities across the United States.
The New York Times, which was first to report the new detention figures late Wednesday, noted that Immigration and Customs Enforcement (ICE) officials were "told that 2,000 arrests a day was the new standard for enforcement." The agency, flush with cash following President Donald Trump's signing of a reconciliation package containing another $70 billion for immigration enforcement, has been instructed to assign 80% of its officers to "arrest operations," according to the Times.
The Trump administration claims to be targeting the "worst of the worst," but available data shows that the percentage of people arrested by ICE despite having no criminal convictions has tended to rise during the agency's mass detention efforts. On Sunday, ICE briefly detained a 56-year-old nun from Nigeria as she walked to church in McAllen, Texas.
"The geniuses at ICE just arrested a Catholic nun, who practices as a nurse, as she was walking to church," Sen. Sheldon Whitehouse (D-RI) wrote in response to Sister Leticia Ugboaja's detention. "Our Republican colleagues think they need even more money. Had enough?"
The Times reported that immigration attorneys across the US "have been on alert" as ICE arrests surge, though much more quietly than earlier blitzes in Minneapolis—where federal immigration agents killed two US citizens—and other major cities, where groups of armed and masked officers roamed the streets and menaced neighborhoods.
"Cindy Blandon, an immigration attorney in Miami, said that one of her clients, a Nicaraguan father of two children, had an immigration court hearing set for 2027, but was arrested by ICE on Monday during a routine check-in," the Times reported. "And in Utah, Ysabel Lonazco, an immigration attorney, has noticed an uptick as well... One of her clients, Arturo, a 48-year-old Mexican man, was arrested in Salt Lake City on his way to a soccer game on Sunday, according to his wife, Veronica. She said the arrest had shattered their family."
ICE also appears to be ignoring a federal judge's order last week curtailing arrests at immigration courthouses. According to The Intercept:
On Thursday, U.S. Immigration and Customs Enforcement agents arrested an Ecuadorian man at a court at 26 Federal Plaza and a man from the Dominican Republic at another court at 290 Broadway, both in Lower Manhattan. The arrests continued on Monday, when ICE agents detained a third man, originally from Guatemala, at 290 Broadway.
In legal filings challenging the detentions of the men taken Thursday, advocates with the nonprofit Make the Road New York accused ICE of not only violating their clients’ right to due process, but also of brazenly flouting a federal court order.
Murad Awawdeh, president and CEO of the New York Immigration Coalition, told The Intercept that "we’re witnessing ICE, yet again, operate in a lawless and rogue fashion and not following court orders."
“We’re supposedly a nation under the rule of law, and our judicial branch has said that this agency must stop engaging in this lawless behavior, and they continue to do so," said Awawdeh.
ICE is currently headed by Acting Director David Venturella, a former private prison executive. A record number of people have died in ICE custody under the second Trump administration.
Last week, Trump announced that he intends to nominate former Oklahoma state trooper Lance Schroyer to lead ICE in a permanent capacity.
Marcos Charles, the head of ICE’s deportation wing, cheered the recent arrest surge in an email to agency personnel earlier this week. On Saturday, ICE officers arrested 2,400 people.
“I want to personally thank each of you for your extraordinary efforts this past weekend,” Charles wrote, according to the Times. “Through your dedication, professionalism, and unwavering commitment to our mission, enforcement and removal operations achieved remarkable operational results."
Environmental and public health advocates on Wednesday ripped the US Environmental Protection Agency's fifth approval of a "forever chemical" pesticide during the current term of President Donald Trump, who campaigned on a promise to "Make America Healthy Again."
Despite that pledge, Trump's second administration—much like his first—has served the pesticide industry in various ways, including by putting out a MAHA report that echoes industry talking points, installing a former industry lobbyist in a key EPA post, backing Bayer-owned Monsanto over cancer patients at the US Supreme Court, and issuing an executive order that mandates the production of glyphosate.
Under Trump, the EPA has also approved or reapproved various controversial pesticides, from atrazine and dicamba to trifludimoxazin, which was approved late Tuesday. Like diflufenican and epyrifenacil, which were authorized by the EPA earlier Tuesday, as well as cyclobutrifluram and isocycloseram, which got a green light from the agency last November, trifludimoxazin is what some scientists and campaigners call a forever chemical pesticide.
Per- and polyfluoroalkyl substances (PFAS)—which have been used in not only pesticides but also fabrics, firefighting foam, nonstick cookware, and other household products—are widely known as forever chemicals because they don't break down naturally. They're also linked to a range of health issues, including various cancers.
"This is the PFAS presidency brought to you by Donald Trump and EPA Administrator Lee Zeldin," Nathan Donley, environmental health science director at the Center for Biological Diversity, declared Wednesday.
As with his Tuesday critique of the Trump EPA approving diflufenican and epyrifenacil, Donley pointed to the Supreme Court's recent ruling in favor of Trump-backed Bayer, rather than the thousands of Americans who argue that Monsanto's glyphosate-based weedkiller Roundup caused their cancer.
"Waiting to open the floodgates on new pesticide approvals until after the Supreme Court granted immunity to pesticide companies takes a special kind of callousness," he said.
Bill Freese, science director at Center for Food Safety (CFS), similarly said Wednesday that "with yesterday's pesticide approvals, the Trump administration's EPA is once again showing its disdain for Americans' health and the natural world."
"The EPA's pesticide division is seemingly no longer able to recognize evidence that a pesticide causes cancer, even when it's the pesticide company's own studies that show it," he continued. "And as per usual, EPA dismisses out of hand incriminating independent studies by scientists not affiliated with the pesticide industry."
In addition to the PFAS pesticides, the EPA is under fire this week for approving new uses for chlormequat, a non-PFAS pesticide tied to reproductive issues, and the fungicide fluoxapiprolin.
CFS co-executive director Sylvia Wu pointed out that the agency dismissed studies showing that fluoxapiprolin and epyrifenacil both produce tumors in laboratory rodents and classified both as "not likely to be carcinogenic to humans."
"The EPA's illegitimate rejection of the evidence that these two pesticides cause cancer is very similar to the tricks it pulled in denying glyphosate could cause cancer," Wu said. "These blatant violations of the agency's own cancer guidelines are unacceptable."
As for chlormequat, Freese said that "EPA should never have approved this endocrine-disrupting pesticide, particularly since its persistence and potential for widespread use on wheat and other widely consumed grains will mean universal exposure."
Already, "chlormequat is found in the urine of 90% of Americans, thought to come mostly from residues on imported foods where the pesticide has been used," the Center for Biological Diversity noted Wednesday. Like Freese, the group warned that "approval of its use on US wheat and oats ensures that exposure to the US population will increase dramatically."